DR10624 Subcutaneous Injection — clinical trials using this drug

Public-registry trials using DR10624 Subcutaneous Injection that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.

Trial	Sponsor	Condition	Phase	Sites
A Phase 3 Trial of DR10624 Versus Placebo in Patients With Severe Hypertriglyceridemia	Zhejiang Doer Biologics Co., Ltd.	Severe Hypertriglyceridemia	PHASE3	1

Registry history

First registered study	May 2022 — NCT05378893 (Zhejiang Doer Biologics Co., Ltd.)
Registered studies matching this name	5 all-time · 0 currently recruiting

Source: ClinicalTrials.gov, the public trial registry.

Free site-risk snapshot for any of these trials

Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Related drugs & trials

Trialed alongside

← Eichor home · All tracked trials · Severe Hypertriglyceridemia studies · Weekly briefs

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →